SFA Therapeutics: Latest News, Top Stories & Analysis

SFA Therapeutics Extends Patent Protection for Drug Platform

May 31, 2026May 30, 2026 - by Timothy Alexander

JENKINTOWN, PA — SFA Therapeutics has secured a new U.S. patent covering a class of modified short-chain fatty acid compounds, strengthening intellectual property protection around its drug development platform and …

Regional

SFA Therapeutics Reports Promising Phase 1b Results for Oral Psoriasis Treatment

March 8, 2025March 7, 2025 - by Timothy Alexander

JENKINTOWN, PA — SFA Therapeutics, Inc. has announced encouraging results from its Phase 1b clinical trial of SFA-002, an oral drug candidate aimed at treating mild-to-moderate psoriasis. The study demonstrated both …